These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17237375)

  • 1. A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity.
    Giustiniani J; Marie-Cardine A; Bensussan A
    J Immunol; 2007 Feb; 178(3):1293-300. PubMed ID: 17237375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD160: a unique activating NK cell receptor.
    Le Bouteiller P; Tabiasco J; Polgar B; Kozma N; Giustiniani J; Siewiera J; Berrebi A; Aguerre-Girr M; Bensussan A; Jabrane-Ferrat N
    Immunol Lett; 2011 Aug; 138(2):93-6. PubMed ID: 21324341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human and mouse mast cells express and secrete the GPI-anchored isoform of CD160.
    Ortonne N; Ram-Wolff C; Giustiniani J; Marie-Cardine A; Bagot M; Mecheri S; Bensussan A
    J Invest Dermatol; 2011 Apr; 131(4):916-24. PubMed ID: 21191401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset.
    Barakonyi A; Rabot M; Marie-Cardine A; Aguerre-Girr M; Polgar B; Schiavon V; Bensussan A; Le Bouteiller P
    J Immunol; 2004 Nov; 173(9):5349-54. PubMed ID: 15494480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation.
    Abecassis S; Giustiniani J; Meyer N; Schiavon V; Ortonne N; Campillo JA; Bagot M; Bensussan A
    J Invest Dermatol; 2007 May; 127(5):1161-6. PubMed ID: 17218942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
    Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
    Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and nonclassical MHC class I and regulates NK cell activation.
    Maeda M; Carpenito C; Russell RC; Dasanjh J; Veinotte LL; Ohta H; Yamamura T; Tan R; Takei F
    J Immunol; 2005 Oct; 175(7):4426-32. PubMed ID: 16177084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation.
    Giustiniani J; Bensussan A; Marie-Cardine A
    J Immunol; 2009 Jan; 182(1):63-71. PubMed ID: 19109136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival.
    D'Addio F; Ueno T; Clarkson M; Zhu B; Vergani A; Freeman GJ; Sayegh MH; Ansari MJ; Fiorina P; Habicht A
    PLoS One; 2013; 8(4):e60391. PubMed ID: 23593209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible pathogenic role of the transmembrane isoform of CD160 NK lymphocyte receptor in paroxysmal nocturnal hemoglobinuria.
    Giustiniani J; Alaoui SS; Marie-Cardine A; Bernard J; Olive D; Bos C; Razafindratsita A; Petropoulou A; de Latour RP; Le Bouteiller P; Bagot M; Socié G; Bensussan A
    Curr Mol Med; 2012 Feb; 12(2):188-98. PubMed ID: 22172098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier.
    Del Rio ML; Bravo Moral AM; Fernandez-Renedo C; Buhler L; Perez-Simon JA; Chaloin O; Alvarez Nogal R; Fernandez-Caso M; Rodriguez-Barbosa JI
    Transl Res; 2017 Mar; 181():83-95.e3. PubMed ID: 27702550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejection.
    Del Rio ML; Nguyen TH; Tesson L; Heslan JM; Gutierrez-Adan A; Fernandez-Gonzalez R; Gutierrez-Arroyo J; Buhler L; Pérez-Simón JA; Anegon I; Rodriguez-Barbosa JI
    Transl Res; 2022 Jan; 239():103-123. PubMed ID: 34461306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity.
    Le Bouteiller P; Barakonyi A; Giustiniani J; Lenfant F; Marie-Cardine A; Aguerre-Girr M; Rabot M; Hilgert I; Mami-Chouaib F; Tabiasco J; Boumsell L; Bensussan A
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16963-8. PubMed ID: 12486241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression.
    Nikolova M; Marie-Cardine A; Boumsell L; Bensussan A
    Int Immunol; 2002 May; 14(5):445-51. PubMed ID: 11978774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment.
    Rabot M; El Costa H; Polgar B; Marie-Cardine A; Aguerre-Girr M; Barakonyi A; Valitutti S; Bensussan A; Le Bouteiller P
    Int Immunol; 2007 Apr; 19(4):401-9. PubMed ID: 17307798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD160 isoforms and regulation of CD4 and CD8 T-cell responses.
    El-Far M; Pellerin C; Pilote L; Fortin JF; Lessard IA; Peretz Y; Wardrop E; Salois P; Bethell RC; Cordingley MG; Kukolj G
    J Transl Med; 2014 Sep; 12():217. PubMed ID: 25179432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
    Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin.
    Sako N; Schiavon V; Bounfour T; Dessirier V; Ortonne N; Olive D; Ram-Wolff C; Michel L; Sicard H; Marie-Cardine A; Bagot M; Bensussan A; Schmitt C
    Cytometry A; 2014 Oct; 85(10):869-82. PubMed ID: 25044837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus-specific human CD8(+) T cells.
    Merino J; Ramírez N; Moreno C; Toledo E; Fernández M; Sánchez-Ibarrola A
    Clin Exp Immunol; 2007 Jul; 149(1):87-96. PubMed ID: 17425655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.